De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

DNA Chip Research Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ryo Matoba

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	14.3yrs
Eigendom CEO	0.1%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	5.3yrs

Recente managementupdates

Recent updates

CEO

Ryo Matoba (59 yo)

14.3yrs

Tenure

Mr. Ryo Matoba, Ph.D. has been the President of DNA Chip Research Inc. since June 2010 and has been its Chief Executive Officer since June 2012. Mr. Matoba has been a Representative Director of DNA Chip Re...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Ryo Matoba	President	17.3yrs	geen gegevens	0.13% ¥ 6.7m
Keiji Sato	GM of Diagnostic Business Headquarters & Director	5.3yrs	geen gegevens	0.19% ¥ 9.7m
Shoko Kawamoto	Independent Outside Director	3.3yrs	geen gegevens	geen gegevens

5.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 2397 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).

DNA Chip Research Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

DNA Chip Research Inc., Annual General Meeting, Jun 26, 2024

DNA Chip Research Inc., Annual General Meeting, Jun 21, 2023

DNA Chip Research Inc., Annual General Meeting, Jun 22, 2022

Recent updates

DNA Chip Research Inc. to Report Q2, 2025 Results on Nov 07, 2024

First quarter 2025 earnings released: JP¥2.96 loss per share (vs JP¥15.11 loss in 1Q 2024)

New major risk - Share price stability

Insufficient new directors

Full year 2024 earnings released: JP¥39.02 loss per share (vs JP¥61.70 loss in FY 2023)

DNA Chip Research Inc., Annual General Meeting, Jun 26, 2024

New minor risk - Shareholder dilution

DNA Chip Research Inc. to Report Fiscal Year 2024 Results on May 10, 2024

Third quarter 2024 earnings released: JP¥11.97 loss per share (vs JP¥18.70 loss in 3Q 2023)

DNA Chip Research Inc. announced that it expects to receive ¥269.99972 million in funding from Mitsui Chemicals, Inc.

New minor risk - Share price stability

DNA Chip Research Inc. to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: JP¥10.24 loss per share (vs JP¥16.91 loss in 2Q 2023)

DNA Chip Research Inc. to Report Q2, 2024 Results on Nov 02, 2023

First quarter 2024 earnings released: JP¥15.11 loss per share (vs JP¥18.65 loss in 1Q 2023)

DNA Chip Research Inc. to Report Q1, 2024 Results on Jul 27, 2023

Full year 2023 earnings released: JP¥61.70 loss per share (vs JP¥23.15 loss in FY 2022)

DNA Chip Research Inc., Annual General Meeting, Jun 21, 2023

Third quarter 2023 earnings released: JP¥18.70 loss per share (vs JP¥6.74 loss in 3Q 2022)

DNA Chip Research Inc. announced that it expects to receive ¥279.99974 million in funding from Mitsui Chemicals, Inc.

DNA Chip Research Inc. to Report Q3, 2023 Results on Jan 24, 2023

Second quarter 2023 earnings released: JP¥16.91 loss per share (vs JP¥10.19 loss in 2Q 2022)

DNA Chip Research Inc. to Report Q2, 2023 Results on Oct 28, 2022

First quarter 2023 earnings released: JP¥18.65 loss per share (vs JP¥12.61 loss in 1Q 2022)

DNA Chip Research Inc. to Report Q1, 2023 Results on Jul 28, 2022

DNA Chip Research Inc., Annual General Meeting, Jun 22, 2022

Full year 2022 earnings released: JP¥23.15 loss per share (vs JP¥30.30 loss in FY 2021)

DNA Chip Research Inc. to Report Fiscal Year 2022 Results on Apr 28, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥10.19 loss per share (vs JP¥10.36 loss in 2Q 2021)

First quarter 2022 earnings released: JP¥12.61 loss per share (vs JP¥13.12 loss in 1Q 2021)

Full year 2021 earnings released: JP¥30.30 loss per share (vs JP¥25.15 loss in FY 2020)

DNA Chip Research Inc. to Report Fiscal Year 2021 Results on Apr 22, 2021

Third quarter 2021 earnings released: JP¥8.46 loss per share (vs JP¥11.40 loss in 3Q 2020)

Third quarter 2021 earnings released: JP¥8.46 loss per share

DNA Chip Research Inc. to Report Q3, 2021 Results on Jan 21, 2021

New 90-day low: JP¥644

New 90-day low: JP¥747

DNA Chip Research Inc. to Report Q2, 2021 Results on Oct 22, 2020

CEO

Tenure

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd